CORRESP Filing
IceCure Medical Ltd.
Date: March 23, 2026 · CIK: 0001584371 · Accession: 0001213900-26-032525
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290046
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission Washington, D.C. 20549 Re: IceCure Medical Ltd. (CIK 0001584371) Registration Statement on Form F-3 (File No. 333-290046) (the "Registration Statement") Request for Acceleration of Effective Date
Dear Sir or Madam:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), IceCure Medical Ltd. (the "Registrant") hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective on March 24, 2026 at 9:00 a.m., Eastern Time, or as soon as practicable thereafter.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
IceCure Medical Ltd.
Show Raw Text
CORRESP 1 filename1.htm IceCure Medical Ltd. 7 Ha'Eshel St., PO Box 3163 Caesarea, 3079504 Israel March 23, 2026 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: IceCure Medical Ltd. (CIK 0001584371) Registration Statement on Form F-3 (File No. 333-290046) (the "Registration Statement") Request for Acceleration of Effective Date Dear Sir or Madam: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), IceCure Medical Ltd. (the "Registrant") hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective on March 24, 2026 at 9:00 a.m., Eastern Time, or as soon as practicable thereafter. The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092 and that such effectiveness also be confirmed in writing. Very truly yours, IceCure Medical Ltd. By: /s/ Eyal Shamir Name: Eyal Shamir Title: Chief Executive Officer